<div id="readability-page-1"><div> <div> , /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: NV5 Global, Inc. (NASDAQ: NVEE)'s sale to Acuren Corporation. Under the terms of the proposed transaction, NV5 shareholders will receive approximately $23.00 per share consisting of $10.00 in cash and an estimated $13.00 in shares of Acuren common stock at closing. If you are a NV5 shareholder, click here to learn more about your rights and options. Carisma Therapeutics Inc. (NASDAQ: CARM)'s merger with OrthoCellix, Inc. Upon completion of the proposed transaction, existing Carisma shareholders are expected to own approximately 10% of the combined company. If you are a Carisma shareholder, click here to learn more about your legal rights and options. Heliogen, Inc. (OTCQX: HLGN)'s sale to Zeo Energy Corp. Upon closing of the proposed transaction, Heliogen's securityholders will receive shares of Zeo's Class A common stock valued at approximately $10 million in the aggregate, based on a Zeo Class A common stock price of $1.5859 per share, and subject to an adjustment mechanism based on Heliogen's net cash at the closing. If you are a Heliogen shareholder, click here to learn more about your rights and options. Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected]. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Halper Sadeh LLC Daniel Sadeh, Esq. Zachary Halper, Esq. (212) 763-0060 [email protected] [email protected] https://www.halpersadeh.com SOURCE Halper Sadeh LLP <img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwNzE2Jk5ld3NJdGVtSWQ9TlkzMTU0MiZUcmFuc21pc3Npb25fSWQ9MjAyNTA3MTYxMTMyUFJfTkVXU19VU1BSX19fX19OWTMxNTQy?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwNzE2Jk5ld3NJdGVtSWQ9TlkzMTU0MiZUcmFuc21pc3Npb25fSWQ9MjAyNTA3MTYxMTMyUFJfTkVXU19VU1BSX19fX19OWTMxNTQy"/></div> </div></div>

NVEE

HLGN

CARM

Halper Sadeh LLC is investigating NV5 Global, Inc. (NASDAQ: NVEE), Carisma Therapeutics Inc. (NASDAQ: CARM), and Heliogen, Inc. (OTCQX: HLGN) for potential violations of federal securities laws and breaches of fiduciary duties to shareholders. The investigations relate to NV5's sale to Acuren, Carisma's merger with OrthoCellix, and Heliogen's sale to Zeo Energy Corp. Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options regarding these transactions.

11:32 ET SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVEE, CARM, HLGN on Behalf of Shareholders